Exploring AI-powered cell simulations and the launch of the world’s first virtual lab
Artificial intelligence and machine learning (AI/ML) are fundamentally changing the world of drug discovery, enabling researchers to identify the potential…
All articles by Miranda Mclaren
Miranda Mclaren
-
-
Five considerations when scaling up mAbs in partnership with a CDMO
Scaling up production is a key stage in the lifetime of a monoclonal antibody (mAb), fraught with the risk of…
-
CDMO insights podcast series: Our Experience is Your Strength | Episode #2 Gene Therapy Fill-Finish
“You may design for 12 hours,” says Xufeng Sun, Vice President of Manufacturing Science & Technology at Sharp Sterile, “but…
-
Real-world evidence as a strategic access lever in rare disease drug development
More than 30 million people across Europe live with a rare disease, yet fewer than 5% of these conditions have…
-
Enhancing solubility of targeted protein degraders: Better strategies for bioavailability
Targeted protein degradation (TPD) represents a transformative approach within the field of therapeutic intervention, specifically for diseases where traditional small-molecule…
-
US trade tariffs and the potential impact on pharma supply chains
When Donald Trump was elected the 47th president of the United States of America, the outlook for pharmaceuticals was unclear,…
-
Overcoming technical challenges in gene therapy product fill-finish operations
Gene therapy holds transformative potential in treating a wide range of diseases—from cancer and genetic disorders to infectious diseases. While…
-
Orphan drug market access in Europe: HTA challenges and the growing potential of RWE
Europe has witnessed strong growth in orphan drug approvals over the past decade, yet for pharmaceutical innovators, securing market access…
-
Beyond oncology: The expanding potential of cell and gene therapies
Cell and gene therapies (CGTs) have established themselves as revolutionary treatment methods in the world of oncology, where they have…
-
Clinical trial challenges in China: How a Sharp and ClinsChain pairing is breaking down barriers
The market for clinical trials in China is currently experiencing significant growth, driven by increasing activity from both Chinese sponsors…